These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Immunohistochemical molecular phenotypes of gastric cancer based on SOX2 and CDX2 predict patient outcome. Camilo V; Barros R; Celestino R; Castro P; Vieira J; Teixeira MR; Carneiro F; Pinto-de-Sousa J; David L; Almeida R BMC Cancer; 2014 Oct; 14():753. PubMed ID: 25300947 [TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus positivity, not mismatch repair-deficiency, is a favorable risk factor for lymph node metastasis in submucosa-invasive early gastric cancer. Park JH; Kim EK; Kim YH; Kim JH; Bae YS; Lee YC; Cheong JH; Noh SH; Kim H Gastric Cancer; 2016 Oct; 19(4):1041-1051. PubMed ID: 26573601 [TBL] [Abstract][Full Text] [Related]
7. Sox2 expression in human stomach adenocarcinomas with gastric and gastric-and-intestinal-mixed phenotypes. Tsukamoto T; Mizoshita T; Mihara M; Tanaka H; Takenaka Y; Yamamura Y; Nakamura S; Ushijima T; Tatematsu M Histopathology; 2005 Jun; 46(6):649-58. PubMed ID: 15910596 [TBL] [Abstract][Full Text] [Related]
8. Cell cycle regulators, APC/beta-catenin, NF-kappaB and Epstein-Barr virus in gastric carcinomas. Kim B; Byun SJ; Kim YA; Kim JE; Lee BL; Kim WH; Chang MS Pathology; 2010 Jan; 42(1):58-65. PubMed ID: 20025482 [TBL] [Abstract][Full Text] [Related]
9. Down-regulation of a gastric transcription factor, Sox2, and ectopic expression of intestinal homeobox genes, Cdx1 and Cdx2: inverse correlation during progression from gastric/intestinal-mixed to complete intestinal metaplasia. Tsukamoto T; Inada K; Tanaka H; Mizoshita T; Mihara M; Ushijima T; Yamamura Y; Nakamura S; Tatematsu M J Cancer Res Clin Oncol; 2004 Mar; 130(3):135-45. PubMed ID: 14655050 [TBL] [Abstract][Full Text] [Related]
10. Sox2 expression is maintained while gastric phenotype is completely lost in Cdx2-induced intestinal metaplastic mucosa. Mutoh H; Sashikawa M; Sugano K Differentiation; 2011 Feb; 81(2):92-8. PubMed ID: 21036460 [TBL] [Abstract][Full Text] [Related]
11. [Epstein-Barr virus infection and p16(INK4a) overexpression in gastric adenocarcinoma]. Wang P; Zhang Q; Yang JF; Cheng ZN; Zhang K; Yu DH Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Aug; 22(4):244-6. PubMed ID: 19105332 [TBL] [Abstract][Full Text] [Related]
12. Interrelationship between Epstein-Barr virus infection in gastric carcinomas and the expression of apoptosis-associated proteins. Ishii H; Gobé G; Kawakubo Y; Sato Y; Ebihara Y Histopathology; 2001 Feb; 38(2):111-9. PubMed ID: 11207824 [TBL] [Abstract][Full Text] [Related]
13. [Clinicopathologic and immunohistochemical study on early gastric signet-ring cell carcinoma]. Xiong ZF; Xiao H; Tan YS Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):442-6. PubMed ID: 21055171 [TBL] [Abstract][Full Text] [Related]
14. Zinc finger E-box binding factor 1 plays a central role in regulating Epstein-Barr virus (EBV) latent-lytic switch and acts as a therapeutic target in EBV-associated gastric cancer. Zhao J; Jin H; Cheung KF; Tong JH; Zhang S; Go MY; Tian L; Kang W; Leung PP; Zeng Z; Li X; To KF; Sung JJ; Yu J Cancer; 2012 Feb; 118(4):924-36. PubMed ID: 21717425 [TBL] [Abstract][Full Text] [Related]
15. Mucin-Phenotype and Expression of the Protein V-Set and Immunoglobulin Domain Containing 1 (VSIG1): New Insights into Gastric Carcinogenesis. Satala CB; Jung I; Gurzu S Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240039 [TBL] [Abstract][Full Text] [Related]
16. Prevalence and characteristics of Epstein-Barr virus-associated gastric carcinomas in Tunisia. Trimeche M; Ksiâa F; Ziadi S; Mestiri S; Hachana M; Gacem RB; Sriha B; Korbi S Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1001-7. PubMed ID: 19491698 [TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic characteristics of Epstein-Barr virus-incorporated gastric cancers in Korea. Chang MS; Lee HS; Kim CW; Kim YI; Kim WH Pathol Res Pract; 2001; 197(6):395-400. PubMed ID: 11432666 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemically detectable Cdx2 is present in intestinal phenotypic elements in early gastric cancers of both differentiated and undifferentiated types, with no correlation to non-neoplastic surrounding mucosa. Mizoshita T; Tsukamoto T; Inada K; Ogasawara N; Hirata A; Kato S; Joh T; Itoh M; Yamamura Y; Tatematsu M Pathol Int; 2004 Jun; 54(6):392-400. PubMed ID: 15144397 [TBL] [Abstract][Full Text] [Related]
19. Mucin phenotype expression of gastric neuroendocrine neoplasms: analysis of histopathology and carcinogenesis. Domori K; Nishikura K; Ajioka Y; Aoyagi Y Gastric Cancer; 2014 Apr; 17(2):263-72. PubMed ID: 23828549 [TBL] [Abstract][Full Text] [Related]
20. Re-evaluation of phenotypic expression in undifferentiated-type early gastric adenocarcinomas using mucin core protein and CDX2. Ikarashi S; Nishikura K; Ajioka Y; Aoyagi Y Gastric Cancer; 2013 Apr; 16(2):208-19. PubMed ID: 22829163 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]